AI assistant
Sending…
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2021
May 24, 2021
32163_dirs_2021-05-24_9efc9a68-5bd3-4410-9246-fb54c557aa43.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2021-05-24
Reporting Person: Tupper Colleen (EVP & Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| No securities beneficially owned | 0 | Direct |
More from COLLEGIUM PHARMACEUTICAL, INC
Share Issue/Capital Change
2026
Jun 1
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Report Publication Announcement
2026
May 7
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Board/Management Information
2026
Apr 7
Major Shareholding Notification
2026
Mar 26